BRIAN GOMES: Open Payments
NPI 1669972444 · CROMWELL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 48 payments from 11 companies in 2025. Trend: 2023 $118 · 2024 $190 · 2025 $1,555
Food & beverage: $1,555
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 19 | $570 |
| ViiV Healthcare Company | 11 | $391 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $159 |
| Janssen Pharmaceuticals, Inc | 1 | $121 |
| ABBVIE INC. | 4 | $77 |
| Alkermes, Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $39 |
| REVANCE THERAPEUTICS, INC. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: CABENUVA, CAPLYTA, SPRAVATO, Yeztugo, APRETUDE, Descovy, Epclusa, VRAYLAR.
Industry payments across CT — which companies pay providers there.
